Inside the scientific demo practical experience with Xyrem in narcolepsy/cataplexy sufferers at therapeutic doses, two sufferers noted anxiousness and a person documented sleeplessness subsequent abrupt discontinuation within the termination on the medical demo; in the two clients with anxiousness, the frequency of cataplexy had amplified markedly